BackProvectus Biopharmaceuticals Overview

Provectus Biopharmaceuticals Net Income

Profitability analysis for PVCT.

Quarterly Net Income

-$1.29M
↓ 13.19% YoY

As of Mar 2026

Annual Net Income (TTM)

-$5.62M
↓ 4.09% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin